UNSPSC 85893834: High dose rate (hdr) brachytherapy of prostate using californium 252 (cf-252)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of prostate using californium 252 (cf-252). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DV109CZ

UNSPSC 85893834 High dose rate (HDR) brachytherapy of prostate using californium 252 (Cf-252) is a Commodity code that describes a specialized radiation oncology procedure — targeted internal radiation therapy for prostate cancer treatment using californium-252 sources. State and local governments procure this service through health departments, hospital systems, cancer treatment centers, and public healthcare agencies that operate or contract for oncology programs. The service involves clinical delivery, source management, patient planning, and post-treatment monitoring under medical physicist and radiation oncologist supervision, typically offered as part of comprehensive cancer care networks.

The available record shows minimal recent state and local procurement activity under this code. A single recent opportunity from Boswell, Mississippi (RFQP 3382-26-R-RFQP-00005-V01, posted April 2, 2026, due April 24, 2026) is tagged to this code but solicits an Occupational Therapist position — work plainly unrelated to brachytherapy or radiation oncology. This mismatch suggests either a coding error in the state or local procurement system or that the code is rarely applied to actual state and local purchases. No other representative opportunities appear in the recent record. Without corroborating solicitations from health departments, public hospital systems, or cancer treatment programs, this code shows little actionable recent activity for business development purposes.